AU2023204240A1 — Donepezil transdermal delivery system
Assigned to Corium LLC · Expires 2023-07-27 · 3y expired
What this patent protects
A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises drug reservoir layer comprised of an acrylate copolymer, glycerine, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is p…
USPTO Abstract
A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises drug reservoir layer comprised of an acrylate copolymer, glycerine, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent that is bioequivalent to administration of the therapeutic agent orally. See Fig. 5A. WO 2018/022817 PCT/US2017/044050 00 of(0 ~PSI 0 0 0 00 0 T f) ( (IW/C,, uoieiueoo ~z~~u(3 wsld 9 0
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.